首页> 外文期刊>Chemistry Select >The Evaluation of Anticancer, Antioxidant, Antidiabetic and Anticholinergic Potentials of Endemic Rhabdosciadium microcalycinum Supported by Molecular Docking Study
【24h】

The Evaluation of Anticancer, Antioxidant, Antidiabetic and Anticholinergic Potentials of Endemic Rhabdosciadium microcalycinum Supported by Molecular Docking Study

机译:由分子对接研究支持的流行性透明度象征微分析的抗癌,抗氧化剂,抗糖尿病和抗胆碱能潜力的评估

获取原文
获取原文并翻译 | 示例
           

摘要

Lung cancer is the most common cancer worldwide and the leading cause of cancer-related death. Plant-derived natural products and compounds are an inspiring source of chemo-therapeutic agents. Alzheimer's disease (AD) is linked to the decline of acetylcholine (ACh) effects in the brain, so acetylcholinesterase (AChE) inhibitors are important in the treatment of AD. In this study, the chemical components and bioactivity of ethanolic extract of Rhabdosciadium microcalyci-num (RM) was investigated by various methods. The lipophilic components of RM was determined by gas chromagraphy-mass spectrometry (GC-MS). Antioxidant activicty tests were evaluated with FCAP (Ferrous chelating antioxidant power assay), FRAP (Ferric reducing antioxidant power assay), ABTS (2,2'-Azino-bis(3-ethylbenzothiazoline-6-sulfonic acid) diammo-nium salt assay) and DPPH (2,2-diphenyl-1-picrylhydrazyl assay). The anticancer effect of RM was evaluated by WST-1 (4-[3-(4-iodophenyl)-2-(4-nitrophenyl)-2H-5-tetrazolio]-1,3-benzene di-sulfonate), colony formation, wound healing and CDDE (cell death detection Elisa) analysis on A549 lung cancer cells. Enzyme inhibition effects of RM was determined against AChE and α-glycosidase (AG) enzymes. According to the results of molecular docking found in the study; With a docking score of 4.56 for HP5 protein, 6.23 for BXO protein, 5.25 for AFI protein, 3.90 for gly protein and 7.74 for AChE protein, Telecinobufagin molecule was found to have higher activity than other molecules. After docking calculations, Absorption, Distribution, Metabolism, Excretion and Toxicity (ADME/T) analysis was performed to examine the effects and reactions of molecules on human metabolism. RM inhibited the viability of A549 cells dose-dependent manner (IC_(50)=117.15±8.58 μg/ mL), and it was also observed that RM suppressed colony formation, prevented cell migration and directed the cells to apoptosis. RM has important lipophilic components, and significant antioxidant and enzyme inhibition potential. IC_(50) values of RM for AChE and AG enzymes were found as 35.86 mg/mL, and 10.14 mg/mL, respectively. In conclusion, the findings of this study reveal that ethanol extract from the aerial part of Rhabdosciadium microcalycinum may be a potential therapeutic agent for the treatment of human lung cancer and Alzheimer's disease, due to its phytochemical components.
机译:肺癌是全球最常见的癌症,也是癌症相关死亡的主要原因。植物来源的天然产物和化合物是化学治疗剂的鼓舞人心的来源。阿尔茨海默氏病(AD)与大脑中乙酰胆碱(ACH)作用的下降有关,因此乙酰胆碱酯酶(ACHE)抑制剂在AD治疗中很重要。在这项研究中,通过各种方法研究了伸脂蛋白微科(RM)的乙醇提取物的化学成分和生物活性。 RM的亲脂成分由气体铬质质谱法(GC-MS)确定。用FCAP(铁质螯合抗氧化剂测定法),FRAP(铁还原抗氧化剂分析),ABTS(2,2'-齐诺 - 双子(3-乙基苯甲酰苯二氮唑氨酸-6-硫酸盐)Diammo-nium Asal Assay评估抗氧化剂活测试。和DPPH(2,2-二苯基-1-苯羟基羟基测定法)。 RM的抗癌作用通过WST-1(4- [3-(4-碘)-2-(4-硝基苯基)-2H-5-四唑烷] -1,3-苯苯二磺酸盐,共菌落形成) ,对A549肺癌细胞的伤口愈合和CDDE(细胞死亡检测ELISA)分析。 RM的酶抑制作用是针对ACHE和α-糖苷酶(Ag)酶的。根据研究中发现的分子对接结果; HP5蛋白的对接得分为4.56,BXO蛋白为6.23,AFI蛋白为5.25,Gly蛋白的对接得分为5.25,ACHE蛋白的蛋白质为3.90,Telecinobufagin分子的活性高于其他分子。对接计算后,进行了吸收,分布,代谢,排泄和毒性(ADME/T)分析,以检查分子对人代谢的影响和反应。 RM抑制了A549细胞剂量依赖性方式的活力(IC_(50)= 117.15±8.58μg/ ml),还观察到RM抑制了菌落形成,阻止了细胞迁移并将细胞引导到细胞凋亡。 RM具有重要的亲脂成分,并且具有显着的抗氧化剂和酶抑制潜力。发现ACHE和Ag酶的IC_(50)RM分别为35.86 mg/mL和10.14 mg/ml。总之,这项研究的结果表明,由于其植物化学成分,乙醇含量微科体的乙醇提取物可能是治疗人肺癌和阿尔茨海默氏病的潜在治疗剂。

著录项

  • 来源
    《Chemistry Select》 |2022年第17期|共11页
  • 作者单位

    Department of Molecular Biology and Genetics, Faculty of Arts and Sciences, Bingol University, 12000- Bingol, Turkey;

    Department of Pharmacy Services, Vocational School of Health Services, Bingol University, 12000- Bingol, Turkey;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 英语
  • 中图分类 Online;
  • 关键词

相似文献

  • 外文文献
  • 中文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号